Larvol Delta - AURORA2-A-Study-of-Oncedaily-Oral-ASC30-to-Evaluate-the-Efficacy-and-Safety-in-Adult-Participants-With-Obesity-or-Overweight-With-Type-2-Diabetes

ASC30 - Ascletis

http://clinicaltrials.gov/ct2/show/NCT07743450

Aug 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next